Daniel Bergemalm

Oerebro, T, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Increased perinatal levels of CXCL9, GZMB and MMP-10 are associated with pediatric-onset IBD: A nested case control study within a population-based birth cohort.

Increased perinatal levels of CXCL9, GZMB and MMP-10 are associated with pediatric-onset IBD: A nested case control study within a population-based birth cohort.

Journal: Gastroenterology

Published: March 20, 2026

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Journal: Clinical pharmacology and therapeutics

Published: September 04, 2025

Reply.

Reply.

Journal: Gastroenterology

Published: June 13, 2025

Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).

Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).

Journal: BMJ open

Published: May 06, 2025

Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.

Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.

Journal: Journal of Crohn's & colitis

Published: April 19, 2025

Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study.

Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study.

Journal: BJS open

Published: April 11, 2025

Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study.

Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study.

Journal: United European gastroenterology journal

Published: March 31, 2025

Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.

Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.

Journal: Therapeutic advances in gastroenterology

Published: February 11, 2025

Insulin sensitivity in moderately severe to acute severe ulcerative colitis.

Insulin sensitivity in moderately severe to acute severe ulcerative colitis.

Journal: Scandinavian journal of gastroenterology

Published: January 30, 2025

Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis.

Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 15, 2025

Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.

Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.

Journal: Clinical and experimental gastroenterology

Published: November 06, 2024

Health-related quality of life for patients with inflammatory bowel disease requires more than anti-inflammatory treatment

Health-related quality of life for patients with inflammatory bowel disease requires more than anti-inflammatory treatment

Journal: Lakartidningen

Published: August 14, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026